<DOC>
	<DOCNO>NCT00712374</DOCNO>
	<brief_summary>In area seasonal malaria transmission burden severe disease mortality due malaria mainly among child 5 year age . Intermittent preventive treatment ( IPT ) antimalarial drug give child month transmission season promise new strategy malaria prevention . Studies Senegal , Ghana , Mali The Gambia show approach highly effective . In Senegal , seasonal IPT sulfadoxine-pyrimethamine ( SP ) one dose artesunate result 90 % reduction incidence clinical malaria recent trial Senegal ( Cisse et al. , Lancet 2006 ) . The purpose present project determine public health impact cost effectiveness intervention deliver routine health service community rural area Senegal . Demographic surveillance set rural population three district ( Mbour , Bambey Fatick ) comprise approximately 540,000 people , include 100,000 child 5 yr , serve 54 health post , expansion area cover exist DSS Niakhar . Information birth , death migration , household characteristic socioeconomic status , vaccination status child use bednets , record 6-monthly round household . In select area , death among child 10 year investigate use verbal autopsy . Over four year September 2008 - November 2011 , seasonal IPT ( three monthly administration SP ( sulfalene-pyrimethamine ) plus amodiaquine transmission season year child 3-59 month age ) introduce gradually , step-wedge design , 9 health post 2008 , additional 18 post 2009 , another 18 2010 9 2011 . At end transmission season , cross-sectional survey 2400 child 5 yr age , finger prick blood sample take , used estimate prevalence molecular marker drug resistance Plasmodium falciparum , prevalence anaemia nutritional status child . Malaria incidence monitor passive surveillance health post , health centre , hospital . Cost effectiveness assess . Due change epidemiology malaria study area , upper age limit inclusion increase 5 10 year old September 2009 .</brief_summary>
	<brief_title>Evaluation Public Health Impact Seasonal Intermittent Preventive Treatment ( IPT ) Children Senegal</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>Age 3119 month time first administration IPT September Consent mother carer local community History allergy SP AQ Age &lt; 3 month &gt; 119 month time first administration IPT September From 2009 , age inclusion change 359 month 3 month 10 year age .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>119 Months</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Malaria</keyword>
	<keyword>All cause mortality</keyword>
	<keyword>Cost effectiveness</keyword>
</DOC>